Staar Surgical Co

Ownership Transactions Reported by 24 Insiders

Symbol
STAA on Nasdaq
Industry
Ophthalmic Goods
Location
1911 Walker Ave, Monrovia, CA

Insiders trading volume in the past year

Staar Surgical Co executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Broadwood Partners, L.P. 10%+ Owner $917M +$6.59M +0.72% May 9, 2024
Thomas G. Frinzi President & CEO, Director $4.22M Mar 12, 2024
Caren Mason President & CEO, Director $4.13M Jun 6, 2022
Hans-Martin Blickensdoerfer Sr. VP, Comm. Ops, China $2.25M Mar 7, 2022
Patrick F. Williams Chief Financial Officer $1.9M Mar 12, 2024
Warren Foust Chief Operating Officer $1.4M May 8, 2024
Samuel J. Gesten Chief Legal Officer $1.18M Mar 20, 2023
James Francese Sr. VP, Comm. Ops., NA, APAC $1.16M Mar 20, 2023
Scott Barnes Chief Medical Officer $1.13M Mar 20, 2023
Nathaniel Sisitsky General Counsel $1.07M Mar 12, 2024
Magda Michna Chief Clinical, Regulatory, $1.01M May 8, 2024
Robert Studholme Senior VP, Operations $867K Mar 10, 2023
Keith Holliday Chief Technology Officer $763K Mar 20, 2023
Aimee S. Weisner Director $653K +$66.7K +11.4% Jun 20, 2024
Stephen Farrell Director $645K Jun 20, 2024
Jon Hayashida VP, Global Clinical, Medical $442K May 10, 2021
Gilbert H. Kliman Director $283K Dec 1, 2023
Graydon Hansen Sr. VP, Global Operations $266K May 11, 2021
Elizabeth Yeu Lin Director $217K Jun 20, 2024
Lilian Zhou Director $195K Jun 20, 2024
Wei Jiang Director $180K Jun 20, 2024
Arthur C. Butcher Director $160K +$50K +45.5% Aug 12, 2024
Lou Silverman Director $120K Aug 10, 2021
K. Peony Yu Director $75.5K Jun 15, 2023

Recent Insider Transactions by Companies or Individuals for Staar Surgical Co

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.